IFNA2 and systemic lupus erythematosus: Auto-antibodies directed against IFN-α2 have been shown to be present in up to a quarter of SLE patients [47] and could theoretically interfere with quantification of IFN-α2 via the Simoa assay [47], potentially limiting the reliability of this assay in some patients.